Mucofrin (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucofrin, is a mucolytic presented as a sterile solution for inhalation and intravenous use. It reduces mucus viscosity and is employed in the management of chronic bronchitis, acute respiratory distress syndromes, and as an antidote for acetaminophen overdose in appropriate clinical settings.

GNH USA supplies Mucofrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for cross‑border procurement.

Acetylcysteine is used as a mucolytic agent to improve airway clearance in several respiratory conditions.

- Chronic bronchitis: helps loosen thick mucus, facilitating expectoration and improving breathing. - Acute respiratory distress syndrome: reduces sputum viscosity, supporting ventilation strategies. - Acetaminophen (paracetamol) overdose: administered intravenously to replenish glutathione and mitigate hepatic injury.

Acetylcysteine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough or throat irritation - Nausea or vomiting - Mild rash or pruritus - Headache - Fever - Metallic taste

Serious or Rare Side Effects: - Anaphylactoid reaction or severe bronchospasm - Hypotension or cardiovascular collapse - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic enzyme elevation - Acute renal impairment - Pulmonary edema

When using Mucofrin, clinicians should consider several safety measures to minimize risk.

- Indication assessment: verify that mucolytic therapy is appropriate for the patient’s respiratory condition. - Renal/hepatic function: evaluate liver and kidney status before intravenous administration. - Concomitant medications: review for potential interactions, especially nitroglycerin and anticoagulants. - Allergy history: assess for hypersensitivity to acetylcysteine or sulfhydryl compounds. - Monitoring: observe for bronchospasm or anaphylactoid reactions during and after infusion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Acetylcysteine can interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Nitroglycerin: concurrent use may cause profound hypotension. - Activated charcoal: can reduce acetylcysteine absorption when given orally. - Certain chemotherapeutic agents: may increase toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): potential for altered bleeding risk. - Carbapenem antibiotics: may affect renal clearance. - Diuretics: monitor electrolyte balance. - Other mucolytics: additive effects on mucus clearance.